Aptevo Therapeutics enters amendment No. 6 to rights agreement on October 23, 2026
APVO•Aptevo Therapeutics amended its rights agreement on October 23, extending its expiration date to October 23, 2027, and changing the purchase price to $14.56 per one one-thousandth of a preferred share.
1. Amendment details
The amendment extends the rights agreement’s final expiration date to October 23, 2027, and sets the purchase price at $14.56 per one one-thousandth of a preferred share.
